Orthofix Medical Inc. (OFIX)
Orthofix Medical Inc. (OFIX)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 120,278 | 82,025 | 62,860 | 65,606 |
| Restricted cash | 592 | 3,090 | 3,086 | 3,083 |
| Accounts receivable, net of allowances of 8,990 and 8,308, respectively | 137,775 | 135,746 | 130,808 | 129,556 |
| Inventories | 177,818 | 172,319 | 174,042 | 172,993 |
| Prepaid expenses and other current assets | 25,057 | 23,667 | 23,374 | 24,592 |
| Total current assets | 461,520 | 416,847 | 394,170 | 395,830 |
| Property, plant, and equipment, gross | NaN | 380,136 | NaN | NaN |
| Accumulated depreciation | NaN | 250,737 | NaN | NaN |
| Property, plant, and equipment, net | 125,327 | 129,399 | 130,017 | 129,200 |
| Cost | NaN | 218,466 | NaN | NaN |
| Developed Technology | NaN | 64,357 | NaN | NaN |
| Patents | NaN | 45,645 | NaN | NaN |
| Customer Relationships | NaN | 21,221 | NaN | NaN |
| Licensing Agreements And Other | NaN | 13,352 | NaN | NaN |
| Trademarks Finite Lived | NaN | 1,126 | NaN | NaN |
| Accumulated amortization | NaN | 145,701 | NaN | NaN |
| Intangible assets, net | 69,336 | 72,765 | 75,641 | 78,868 |
| Goodwill | 194,934 | 194,934 | 194,934 | 194,934 |
| Other long-term assets | 35,484 | 36,702 | 37,848 | 38,325 |
| Total assets | 886,601 | 850,647 | 832,610 | 837,157 |
| Accounts payable | 54,686 | 58,392 | 50,459 | 45,098 |
| Current portion of long-term debt | NaN | 0 | NaN | NaN |
| Current portion of finance lease liability | 115 | 837 | 814 | 797 |
| Other current liabilities | 106,232 | 111,253 | 108,574 | 102,486 |
| Total current liabilities | 161,033 | 170,482 | 159,847 | 148,381 |
| Long-term debt | 221,335 | 157,391 | 157,219 | 157,047 |
| Long-term portion of finance lease liability | 12,937 | 17,060 | 17,240 | 17,448 |
| Other long-term liabilities | 56,110 | 55,677 | 55,818 | 55,934 |
| Total liabilities | 451,415 | 400,610 | 390,124 | 378,810 |
| Common shares 0.10 par value 100,000 shares authorized 40,382 and 39,834 issued and outstanding as of march 31,2026, and december 31, 2025, respectively | 4,038 | 3,983 | 3,952 | 3,948 |
| Additional paid-in capital | 820,247 | 813,769 | 804,011 | 796,807 |
| Accumulated deficit | -389,241 | -368,333 | -366,111 | -343,316 |
| Accumulated other comprehensive income | 142 | 618 | 634 | 908 |
| Total shareholders equity | 435,186 | 450,037 | 442,486 | 458,347 |
| Total liabilities and shareholders equity | 886,601 | 850,647 | 832,610 | 837,157 |